Tag: Home Infusion Therapy

MURFREESBORO, Tenn. – TailorMed, a technology company that empowers providers and pharmacies to proactively flag patients in need, is partnering with TwelveStone Health Partners to improve access to critical therapies for patients who could not otherwise afford them. TailorMed’s technology matches patients with relevant funding opportunities, drawing on more than 6,000 resources ranging from drug manufacturer co-pay assistance to foundation grants. “This partnership enhances our...

BANNOCKBURN, Ill. – Option Care Health reported net revenue of $1.07 billion and net income of $114.4 million for the second quarter of 2023.  Gross profit was $250.8 million or 23.5% of net revenue, and adjusted EBITDA was $110.1 million for the quarter.  “The Option Care Health team executed on another solid quarter of financial results,” said John Rademacher, CEO. “Our commitment to providing unparalleled care that produces superior clinical outcomes makes...

NETANYA, Israel – Eitan Medical, a global provider of advanced infusion therapy and drug delivery solutions, has launched Eitan Insights, a new cloud-based infusion management system designed to meet the unique needs of home and specialty infusions. Sapphire with its new universal plug and play cellular accessory Sapphire Connect and Avoset with the AvosetGo app are now within reach, connecting and transmitting infusion treatment data to Eitan Insights. Eitan Insights has already been awarded...

WASHINGTON – Home infusion stakeholders believe they have a strong case for Congress passing legislation that would finally bring Medicare coverage in line with that of private insurers.  Introduced June 14 in both the Senate and the House of Representatives, “The Preserving Patient Access to Home Infusion Act” would include pharmacy services as part of the home infusion therapy benefit under Medicare, covering everything from assessments to drug preparation and compounding...

WASHINGTON – Sens. Mark R. Warner, D-Va., and Tim Scott, R-S.C., have reintroduced legislation that will ensure patients maintain access to home infusion therapy.   The Preserving Patient Access to Home Infusion Act, is also sponsored by Reps. Vern Buchanan, R-Fla., Chairman of the House Ways & Means Health Subcommittee, Debbie Dingell, D-Mich., Diana Harshbarger, R-Tenn., and Terri Sewell, D-Ala.  The legislation protects access to Medicare’s home infusion benefit by...

DEERFIELD, Ill. - Walgreens Boots Alliance has sold its remaining 10.8 million shares of Option Care Health, generating about $330 million.  Earlier this year, in March, Walgreens sold 13 million shares of Option Care Health at $30.75 per share. Last year, it sold 11 million shares in the company.  Walgreens says it will use the proceeds from the sale “primarily for debt paydown, continued support of the company’s strategic priorities and healthcare transformation.”  The...

BANNOCKBURN, Ill., and BATON ROUGE, La. – The merger of Option Care Health and Amedisys creates a home care giant with projected annual revenue of $6.2 billion that’s primed to serve a $100 billion addressable market for everything from prevention and maintenance care to acute and post-acute care to end-of-life care.  Option Care, the nation's largest independent provider of home and alternate site infusion services, and Amedisys, a leading provider of home health, hospice...

BANNOCKBURN, Ill. – Option Care Health reported net revenue of $1.02 billion and net income of $39.2 million for the first quarter of 2023.  Gross profit was $229 million, or 22.5% of net revenue, up 14% compared to $200.9 million, or 21.9% of net revenue, in the first quarter of 2022. Adjusted EBITDA was $93.8 million, up 20.6% compared to $77.8 million.  "The Option Care Health team's commitment to providing extraordinary patient care in the post-acute and ambulatory setting...

FRISCO, Texas – Soleo Health CEO Drew Walk has been to the National Home Infusion Association’s 2023-2024 board of directors. Walk joins a group of seasoned home infusion experts on the board. “It is both a privilege and an honor to be asked to serve on NHIA’s board of directors alongside industry leaders and individuals who lead well-established and respected companies in the home infusion arena,” said Walk. “I am proud to have an opportunity to add my voice to...

ROCHESTER HILLS, Mich. – InfuSystem Holdings reported net revenues of $28.8 million and $109.9 million, respectively, for the fourth quarter and full year 2022.  For the quarter, gross profit was $16.1 million, and gross margin was 55.8%; for the full year, gross profit was $62.6 million, and gross margin was 56.9%. Adjusted EBITDA for the full year was $20.7 million, a decrease of 14% vs. the prior year.  “We had a highly productive year in 2022 with solid performance...